Live tape
Top 8, mentions 7d9,301MRNA1,846 mentions▲ +0.09GOOGL1,673 mentions▲ +0.04META1,277 mentions▲ +0.03SNDK1,111 mentions▲ +0.10NVDA1,102 mentions▲ +0.07SPCX867 mentions▲ +0.08NKE737 mentions▲ +0.03MSFT688 mentions▲ +0.05

Equity · Healthcare

MMED

MiniMed Group, Inc. · NasdaqGS

$16.94 +6.74% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 37 sessions
$18 $10 26 May 17 Jul

The line runs $11.20 on 26 May through $16.94 on 17 July, on a scale from $10 to $18. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of MMED over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 37 sessions over that window: $11.20 on 26 May 2026 through $16.94 on 17 July 2026.

Market cap $4.8B
52-week range $10.86 – $18.04
Avg volume 279.2K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 20, 2026

MMED insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 31 Jul 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 11

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
31 Jul 2026 Dallara Que Chief Executive Officer Tax withheld 31,350 $569K
31 Jul 2026 Dianaty Ali EVP Ch. Prod. & Tech Officer Tax withheld 8,012 $145K
31 Jul 2026 Wills Courtney Nelson SVP, Gen. Counsel, Corp. Sec. Tax withheld 1,762 $32K
28 Jul 2026 Chandrasena Gillian SVP, Chief HR Officer Tax withheld 2,099 $37K
28 Jul 2026 Spooner Chad EVP, Chief Financial Officer Tax withheld 23,301 $412K
01 Jul 2026 Chandrasena Gillian SVP, Chief HR Officer Award 44,188
01 Jul 2026 Dallara Que Chief Executive Officer Award 297,618
01 Jul 2026 Dianaty Ali See Remarks Award 131,312
01 Jul 2026 Gyurci John VP, Chief Accounting Officer Award 24,244
01 Jul 2026 Wills Courtney Nelson SVP, Gen. Counsel, Corp. Sec. Award 82,787
01 Jul 2026 Spooner Chad EVP, Chief Financial Officer Award 116,607

MMED reported financials

SEC EDGAR XBRL

MMED reported revenue of $3.1B for the fiscal year ended 24 Apr 2026. Net income over the same period was −$333.0M.

Figure Reported Period
Revenue $3.1B 24 Apr 2026 fiscal year
Net income −$333.0M 24 Apr 2026 fiscal year
Diluted EPS −$1.30 24 Apr 2026 fiscal year
Total assets $4.6B 24 Apr 2026 at period end
Total equity $3.6B 24 Apr 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 24 Apr 2026

MMED earnings

SEC EDGAR
Date Period EPS Revenue
24 Apr 2026 FY 2026 $-1.30 $3.10B
23 Jan 2026 Q3 2026 $-0.47 $790M
25 Apr 2025 FY 2026 $-0.84 $2.72B
24 Jan 2025 Q3 2026 $-0.04 $687M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

MMED institutional holders

SEC Form 13F

6 of the 45 institutional funds we track reported a MMED position for the quarter ended 30 Jun 2026 — a combined $94.6M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Millennium Management Held (±25%) +18.0% shares 3,060,615 $45.8M
Citadel Advisors Held (±25%) +0.5% shares 2,865,703 $42.8M
Tudor Investment Corp Added +1,524.0% shares 258,215 $3.9M
Renaissance Technologies New position 88,300 $1.3M
Two Sigma Investments Added +149.6% shares 40,591 $607K
Point72 Asset Management Trimmed −98.6% shares 15,395 $230K
Balyasny Asset Management Exited
D. E. Shaw & Co. Exited

Source: SEC EDGAR 13F filings

MMED fails-to-deliver

SEC CNS data

On 30 Jul 2026, 474,387 shares of MMED failed to deliver (about $8.7M).

Settlement date Shares failed Notional % of shares out
30 Jul 2026 474,387 $8.7M 0.169%
24 Jul 2026 15,999 $261K 0.006%
23 Jul 2026 848 $14K <0.001%
20 Jul 2026 4,679 $79K 0.002%
13 Jul 2026 19,934 $305K 0.007%
08 Jul 2026 9 $138 <0.001%
07 Jul 2026 4 $61 <0.001%

Source: SEC fails-to-deliver (CNS) data